A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients

Clinical trial NCT03019809 · UNKNOWN

Trial details

NCT number: NCT03019809
Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Wiskott-Aldrich Syndrome Hematopoietic Stem Cell Transplantation Graft Failure

Start date: 2016-06-01
Primary completion: 2018-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.